nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Dactinomycin—testicular cancer	0.161	0.189	CbGbCtD
Fluorescein—ABCB11—Vinblastine—testicular cancer	0.142	0.166	CbGbCtD
Fluorescein—ABCC1—Epirubicin—testicular cancer	0.117	0.137	CbGbCtD
Fluorescein—ABCC1—Vinblastine—testicular cancer	0.101	0.118	CbGbCtD
Fluorescein—ABCC1—Etoposide—testicular cancer	0.0911	0.107	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—testicular cancer	0.0874	0.102	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—testicular cancer	0.0621	0.0727	CbGbCtD
Fluorescein—ABCC1—Methotrexate—testicular cancer	0.0602	0.0704	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—testicular cancer	0.0326	0.0381	CbGbCtD
Fluorescein—Mediastinal disorder—Etoposide—testicular cancer	0.000374	0.00258	CcSEcCtD
Fluorescein—Pain—Bleomycin—testicular cancer	0.000373	0.00257	CcSEcCtD
Fluorescein—Anaphylactic shock—Ifosfamide—testicular cancer	0.000373	0.00257	CcSEcCtD
Fluorescein—Oedema—Ifosfamide—testicular cancer	0.000373	0.00257	CcSEcCtD
Fluorescein—Chills—Etoposide—testicular cancer	0.000372	0.00257	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Methotrexate—testicular cancer	0.000371	0.00256	CcSEcCtD
Fluorescein—Asthenia—Vinblastine—testicular cancer	0.000371	0.00256	CcSEcCtD
Fluorescein—Tremor—Cisplatin—testicular cancer	0.000369	0.00255	CcSEcCtD
Fluorescein—Cerebrovascular accident—Methotrexate—testicular cancer	0.000366	0.00253	CcSEcCtD
Fluorescein—Nervous system disorder—Ifosfamide—testicular cancer	0.000366	0.00252	CcSEcCtD
Fluorescein—Ill-defined disorder—Cisplatin—testicular cancer	0.000366	0.00252	CcSEcCtD
Fluorescein—Skin disorder—Ifosfamide—testicular cancer	0.000362	0.0025	CcSEcCtD
Fluorescein—Hyperhidrosis—Ifosfamide—testicular cancer	0.000361	0.00249	CcSEcCtD
Fluorescein—Feeling abnormal—Bleomycin—testicular cancer	0.00036	0.00248	CcSEcCtD
Fluorescein—Hot flush—Epirubicin—testicular cancer	0.000359	0.00248	CcSEcCtD
Fluorescein—Thrombophlebitis—Doxorubicin—testicular cancer	0.000359	0.00248	CcSEcCtD
Fluorescein—Vomiting—Chlorambucil—testicular cancer	0.000359	0.00247	CcSEcCtD
Fluorescein—Menopausal symptoms—Epirubicin—testicular cancer	0.000356	0.00246	CcSEcCtD
Fluorescein—Malaise—Cisplatin—testicular cancer	0.000355	0.00245	CcSEcCtD
Fluorescein—Dysgeusia—Etoposide—testicular cancer	0.000354	0.00244	CcSEcCtD
Fluorescein—Hypotension—Ifosfamide—testicular cancer	0.000349	0.0024	CcSEcCtD
Fluorescein—Pain—Dactinomycin—testicular cancer	0.000348	0.0024	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000347	0.00239	CcSEcCtD
Fluorescein—Urticaria—Bleomycin—testicular cancer	0.000347	0.00239	CcSEcCtD
Fluorescein—Eczema—Doxorubicin—testicular cancer	0.000346	0.00239	CcSEcCtD
Fluorescein—Cerebrovascular accident—Epirubicin—testicular cancer	0.000343	0.00236	CcSEcCtD
Fluorescein—Dizziness—Vinblastine—testicular cancer	0.000342	0.00236	CcSEcCtD
Fluorescein—Convulsion—Cisplatin—testicular cancer	0.000341	0.00235	CcSEcCtD
Fluorescein—Feeling abnormal—Dactinomycin—testicular cancer	0.000335	0.00231	CcSEcCtD
Fluorescein—Nausea—Chlorambucil—testicular cancer	0.000335	0.00231	CcSEcCtD
Fluorescein—Paraesthesia—Ifosfamide—testicular cancer	0.000335	0.00231	CcSEcCtD
Fluorescein—Ill-defined disorder—Etoposide—testicular cancer	0.000335	0.00231	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000333	0.0023	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000333	0.0023	CcSEcCtD
Fluorescein—Dyspnoea—Ifosfamide—testicular cancer	0.000333	0.00229	CcSEcCtD
Fluorescein—Hot flush—Doxorubicin—testicular cancer	0.000332	0.00229	CcSEcCtD
Fluorescein—Discomfort—Cisplatin—testicular cancer	0.000331	0.00229	CcSEcCtD
Fluorescein—Menopausal symptoms—Doxorubicin—testicular cancer	0.00033	0.00227	CcSEcCtD
Fluorescein—Vomiting—Vinblastine—testicular cancer	0.000329	0.00227	CcSEcCtD
Fluorescein—Malaise—Etoposide—testicular cancer	0.000326	0.00224	CcSEcCtD
Fluorescein—Headache—Vinblastine—testicular cancer	0.000324	0.00223	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000322	0.00222	CcSEcCtD
Fluorescein—Abdominal pain—Dactinomycin—testicular cancer	0.000322	0.00222	CcSEcCtD
Fluorescein—Oedema—Cisplatin—testicular cancer	0.000322	0.00222	CcSEcCtD
Fluorescein—Anaphylactic shock—Cisplatin—testicular cancer	0.000322	0.00222	CcSEcCtD
Fluorescein—Hypersensitivity—Bleomycin—testicular cancer	0.000322	0.00222	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000321	0.00222	CcSEcCtD
Fluorescein—Cardiac arrest—Epirubicin—testicular cancer	0.00032	0.0022	CcSEcCtD
Fluorescein—Pain—Ifosfamide—testicular cancer	0.000319	0.0022	CcSEcCtD
Fluorescein—Loss of consciousness—Etoposide—testicular cancer	0.000317	0.00219	CcSEcCtD
Fluorescein—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000317	0.00219	CcSEcCtD
Fluorescein—Nervous system disorder—Cisplatin—testicular cancer	0.000315	0.00217	CcSEcCtD
Fluorescein—Cough—Etoposide—testicular cancer	0.000315	0.00217	CcSEcCtD
Fluorescein—Tachycardia—Cisplatin—testicular cancer	0.000314	0.00216	CcSEcCtD
Fluorescein—Asthenia—Bleomycin—testicular cancer	0.000313	0.00216	CcSEcCtD
Fluorescein—Convulsion—Etoposide—testicular cancer	0.000313	0.00216	CcSEcCtD
Fluorescein—Skin disorder—Cisplatin—testicular cancer	0.000312	0.00215	CcSEcCtD
Fluorescein—Hypertension—Etoposide—testicular cancer	0.000312	0.00215	CcSEcCtD
Fluorescein—Hyperhidrosis—Cisplatin—testicular cancer	0.000311	0.00214	CcSEcCtD
Fluorescein—Asthma—Methotrexate—testicular cancer	0.00031	0.00214	CcSEcCtD
Fluorescein—Pruritus—Bleomycin—testicular cancer	0.000309	0.00213	CcSEcCtD
Fluorescein—Feeling abnormal—Ifosfamide—testicular cancer	0.000307	0.00212	CcSEcCtD
Fluorescein—Chest pain—Etoposide—testicular cancer	0.000307	0.00212	CcSEcCtD
Fluorescein—Nausea—Vinblastine—testicular cancer	0.000307	0.00212	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000305	0.0021	CcSEcCtD
Fluorescein—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000305	0.0021	CcSEcCtD
Fluorescein—Discomfort—Etoposide—testicular cancer	0.000304	0.00209	CcSEcCtD
Fluorescein—Hypotension—Cisplatin—testicular cancer	0.000301	0.00207	CcSEcCtD
Fluorescein—Hypersensitivity—Dactinomycin—testicular cancer	0.0003	0.00207	CcSEcCtD
Fluorescein—Abdominal discomfort—Methotrexate—testicular cancer	0.000298	0.00205	CcSEcCtD
Fluorescein—Urticaria—Ifosfamide—testicular cancer	0.000296	0.00204	CcSEcCtD
Fluorescein—Cardiac arrest—Doxorubicin—testicular cancer	0.000296	0.00204	CcSEcCtD
Fluorescein—Abdominal pain—Ifosfamide—testicular cancer	0.000295	0.00203	CcSEcCtD
Fluorescein—Anaphylactic shock—Etoposide—testicular cancer	0.000295	0.00203	CcSEcCtD
Fluorescein—Asthenia—Dactinomycin—testicular cancer	0.000292	0.00201	CcSEcCtD
Fluorescein—Asthma—Epirubicin—testicular cancer	0.00029	0.002	CcSEcCtD
Fluorescein—Paraesthesia—Cisplatin—testicular cancer	0.000289	0.00199	CcSEcCtD
Fluorescein—Tachycardia—Etoposide—testicular cancer	0.000288	0.00198	CcSEcCtD
Fluorescein—Dyspnoea—Cisplatin—testicular cancer	0.000287	0.00198	CcSEcCtD
Fluorescein—Skin disorder—Etoposide—testicular cancer	0.000286	0.00197	CcSEcCtD
Fluorescein—Hyperhidrosis—Etoposide—testicular cancer	0.000285	0.00196	CcSEcCtD
Fluorescein—Angina pectoris—Epirubicin—testicular cancer	0.000283	0.00195	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000278	0.00191	CcSEcCtD
Fluorescein—Vomiting—Bleomycin—testicular cancer	0.000278	0.00191	CcSEcCtD
Fluorescein—Hypotension—Etoposide—testicular cancer	0.000275	0.0019	CcSEcCtD
Fluorescein—Rash—Bleomycin—testicular cancer	0.000275	0.0019	CcSEcCtD
Fluorescein—Pain—Cisplatin—testicular cancer	0.000275	0.0019	CcSEcCtD
Fluorescein—Dermatitis—Bleomycin—testicular cancer	0.000275	0.0019	CcSEcCtD
Fluorescein—Hypersensitivity—Ifosfamide—testicular cancer	0.000275	0.0019	CcSEcCtD
Fluorescein—Asthma—Doxorubicin—testicular cancer	0.000269	0.00185	CcSEcCtD
Fluorescein—Asthenia—Ifosfamide—testicular cancer	0.000268	0.00185	CcSEcCtD
Fluorescein—Feeling abnormal—Cisplatin—testicular cancer	0.000265	0.00183	CcSEcCtD
Fluorescein—Paraesthesia—Etoposide—testicular cancer	0.000265	0.00182	CcSEcCtD
Fluorescein—Pruritus—Ifosfamide—testicular cancer	0.000264	0.00182	CcSEcCtD
Fluorescein—Dyspnoea—Etoposide—testicular cancer	0.000263	0.00181	CcSEcCtD
Fluorescein—Angina pectoris—Doxorubicin—testicular cancer	0.000262	0.00181	CcSEcCtD
Fluorescein—Nausea—Bleomycin—testicular cancer	0.000259	0.00179	CcSEcCtD
Fluorescein—Vomiting—Dactinomycin—testicular cancer	0.000259	0.00178	CcSEcCtD
Fluorescein—Rash—Dactinomycin—testicular cancer	0.000257	0.00177	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Etoposide—testicular cancer	0.000254	0.00175	CcSEcCtD
Fluorescein—Pain—Etoposide—testicular cancer	0.000252	0.00174	CcSEcCtD
Fluorescein—Dizziness—Ifosfamide—testicular cancer	0.000247	0.0017	CcSEcCtD
Fluorescein—Feeling abnormal—Etoposide—testicular cancer	0.000243	0.00167	CcSEcCtD
Fluorescein—Nausea—Dactinomycin—testicular cancer	0.000242	0.00167	CcSEcCtD
Fluorescein—Gastrointestinal pain—Etoposide—testicular cancer	0.000241	0.00166	CcSEcCtD
Fluorescein—Vomiting—Ifosfamide—testicular cancer	0.000237	0.00164	CcSEcCtD
Fluorescein—Hypersensitivity—Cisplatin—testicular cancer	0.000237	0.00163	CcSEcCtD
Fluorescein—Bradycardia—Epirubicin—testicular cancer	0.000237	0.00163	CcSEcCtD
Fluorescein—Rash—Ifosfamide—testicular cancer	0.000235	0.00162	CcSEcCtD
Fluorescein—Dermatitis—Ifosfamide—testicular cancer	0.000235	0.00162	CcSEcCtD
Fluorescein—Urticaria—Etoposide—testicular cancer	0.000234	0.00161	CcSEcCtD
Fluorescein—Abdominal pain—Etoposide—testicular cancer	0.000233	0.00161	CcSEcCtD
Fluorescein—Hypoaesthesia—Epirubicin—testicular cancer	0.000231	0.00159	CcSEcCtD
Fluorescein—Asthenia—Cisplatin—testicular cancer	0.000231	0.00159	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—testicular cancer	0.000231	0.00159	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—testicular cancer	0.000225	0.00155	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—testicular cancer	0.000224	0.00155	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—testicular cancer	0.000224	0.00154	CcSEcCtD
Fluorescein—Chills—Methotrexate—testicular cancer	0.000223	0.00154	CcSEcCtD
Fluorescein—Nausea—Ifosfamide—testicular cancer	0.000222	0.00153	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—testicular cancer	0.000219	0.00151	CcSEcCtD
Fluorescein—Hypersensitivity—Etoposide—testicular cancer	0.000217	0.0015	CcSEcCtD
Fluorescein—Erythema—Methotrexate—testicular cancer	0.000216	0.00149	CcSEcCtD
Fluorescein—Cardiac disorder—Epirubicin—testicular cancer	0.000216	0.00149	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—testicular cancer	0.000214	0.00148	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—testicular cancer	0.000212	0.00146	CcSEcCtD
Fluorescein—Asthenia—Etoposide—testicular cancer	0.000211	0.00146	CcSEcCtD
Fluorescein—Angiopathy—Epirubicin—testicular cancer	0.000211	0.00145	CcSEcCtD
Fluorescein—Immune system disorder—Epirubicin—testicular cancer	0.00021	0.00145	CcSEcCtD
Fluorescein—Mediastinal disorder—Epirubicin—testicular cancer	0.00021	0.00144	CcSEcCtD
Fluorescein—Chills—Epirubicin—testicular cancer	0.000209	0.00144	CcSEcCtD
Fluorescein—Pruritus—Etoposide—testicular cancer	0.000208	0.00144	CcSEcCtD
Fluorescein—Vomiting—Cisplatin—testicular cancer	0.000204	0.00141	CcSEcCtD
Fluorescein—Rash—Cisplatin—testicular cancer	0.000203	0.0014	CcSEcCtD
Fluorescein—Dermatitis—Cisplatin—testicular cancer	0.000203	0.0014	CcSEcCtD
Fluorescein—Erythema—Epirubicin—testicular cancer	0.000202	0.0014	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—testicular cancer	0.000201	0.00138	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—testicular cancer	0.0002	0.00138	CcSEcCtD
Fluorescein—Dysgeusia—Epirubicin—testicular cancer	0.000198	0.00137	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—testicular cancer	0.000195	0.00135	CcSEcCtD
Fluorescein—Malaise—Methotrexate—testicular cancer	0.000195	0.00134	CcSEcCtD
Fluorescein—Dizziness—Etoposide—testicular cancer	0.000195	0.00134	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—testicular cancer	0.000194	0.00134	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—testicular cancer	0.000194	0.00134	CcSEcCtD
Fluorescein—Chills—Doxorubicin—testicular cancer	0.000193	0.00133	CcSEcCtD
Fluorescein—Nausea—Cisplatin—testicular cancer	0.000191	0.00132	CcSEcCtD
Fluorescein—Cough—Methotrexate—testicular cancer	0.000189	0.0013	CcSEcCtD
Fluorescein—Ill-defined disorder—Epirubicin—testicular cancer	0.000188	0.00129	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—testicular cancer	0.000187	0.00129	CcSEcCtD
Fluorescein—Vomiting—Etoposide—testicular cancer	0.000187	0.00129	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—testicular cancer	0.000187	0.00129	CcSEcCtD
Fluorescein—Rash—Etoposide—testicular cancer	0.000186	0.00128	CcSEcCtD
Fluorescein—Dermatitis—Etoposide—testicular cancer	0.000186	0.00128	CcSEcCtD
Fluorescein—Headache—Etoposide—testicular cancer	0.000185	0.00127	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—testicular cancer	0.000184	0.00127	CcSEcCtD
Fluorescein—Dysgeusia—Doxorubicin—testicular cancer	0.000183	0.00126	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000183	0.00126	CcSEcCtD
Fluorescein—Malaise—Epirubicin—testicular cancer	0.000183	0.00126	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—testicular cancer	0.000182	0.00125	CcSEcCtD
Fluorescein—Syncope—Epirubicin—testicular cancer	0.000181	0.00125	CcSEcCtD
Fluorescein—Loss of consciousness—Epirubicin—testicular cancer	0.000178	0.00123	CcSEcCtD
Fluorescein—Cough—Epirubicin—testicular cancer	0.000177	0.00122	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—testicular cancer	0.000176	0.00122	CcSEcCtD
Fluorescein—Convulsion—Epirubicin—testicular cancer	0.000175	0.00121	CcSEcCtD
Fluorescein—Nausea—Etoposide—testicular cancer	0.000175	0.00121	CcSEcCtD
Fluorescein—Hypertension—Epirubicin—testicular cancer	0.000175	0.0012	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—testicular cancer	0.000174	0.0012	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—testicular cancer	0.000173	0.00119	CcSEcCtD
Fluorescein—Chest pain—Epirubicin—testicular cancer	0.000172	0.00119	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—testicular cancer	0.000171	0.00118	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000171	0.00118	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—testicular cancer	0.000171	0.00118	CcSEcCtD
Fluorescein—Discomfort—Epirubicin—testicular cancer	0.00017	0.00117	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—testicular cancer	0.000169	0.00116	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—testicular cancer	0.000168	0.00116	CcSEcCtD
Fluorescein—Anaphylactic shock—Epirubicin—testicular cancer	0.000165	0.00114	CcSEcCtD
Fluorescein—Oedema—Epirubicin—testicular cancer	0.000165	0.00114	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—testicular cancer	0.000165	0.00114	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—testicular cancer	0.000165	0.00113	CcSEcCtD
Fluorescein—Cough—Doxorubicin—testicular cancer	0.000163	0.00113	CcSEcCtD
Fluorescein—Shock—Epirubicin—testicular cancer	0.000162	0.00112	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—testicular cancer	0.000162	0.00112	CcSEcCtD
Fluorescein—Nervous system disorder—Epirubicin—testicular cancer	0.000162	0.00112	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—testicular cancer	0.000162	0.00111	CcSEcCtD
Fluorescein—Tachycardia—Epirubicin—testicular cancer	0.000161	0.00111	CcSEcCtD
Fluorescein—Skin disorder—Epirubicin—testicular cancer	0.00016	0.00111	CcSEcCtD
Fluorescein—Hyperhidrosis—Epirubicin—testicular cancer	0.00016	0.0011	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—testicular cancer	0.000159	0.0011	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—testicular cancer	0.000158	0.00109	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000158	0.00109	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—testicular cancer	0.000158	0.00109	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—testicular cancer	0.000157	0.00108	CcSEcCtD
Fluorescein—Hypotension—Epirubicin—testicular cancer	0.000154	0.00106	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—testicular cancer	0.000153	0.00105	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—testicular cancer	0.000153	0.00105	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000152	0.00105	CcSEcCtD
Fluorescein—Pain—Methotrexate—testicular cancer	0.000151	0.00104	CcSEcCtD
Fluorescein—Shock—Doxorubicin—testicular cancer	0.00015	0.00104	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—testicular cancer	0.00015	0.00103	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—testicular cancer	0.000149	0.00103	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—testicular cancer	0.000148	0.00102	CcSEcCtD
Fluorescein—Paraesthesia—Epirubicin—testicular cancer	0.000148	0.00102	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—testicular cancer	0.000148	0.00102	CcSEcCtD
Fluorescein—Dyspnoea—Epirubicin—testicular cancer	0.000147	0.00102	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—testicular cancer	0.000145	0.001	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—testicular cancer	0.000144	0.000995	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—testicular cancer	0.000143	0.000985	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000143	0.000983	CcSEcCtD
Fluorescein—Pain—Epirubicin—testicular cancer	0.000141	0.000974	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—testicular cancer	0.00014	0.000967	CcSEcCtD
Fluorescein—Abdominal pain—Methotrexate—testicular cancer	0.00014	0.000962	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—testicular cancer	0.000137	0.000946	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—testicular cancer	0.000136	0.000939	CcSEcCtD
Fluorescein—Feeling abnormal—Epirubicin—testicular cancer	0.000136	0.000939	CcSEcCtD
Fluorescein—Gastrointestinal pain—Epirubicin—testicular cancer	0.000135	0.000931	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000132	0.00091	CcSEcCtD
Fluorescein—Urticaria—Epirubicin—testicular cancer	0.000131	0.000905	CcSEcCtD
Fluorescein—Pain—Doxorubicin—testicular cancer	0.000131	0.000901	CcSEcCtD
Fluorescein—Abdominal pain—Epirubicin—testicular cancer	0.000131	0.0009	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—testicular cancer	0.00013	0.000897	CcSEcCtD
Fluorescein—Asthenia—Methotrexate—testicular cancer	0.000127	0.000873	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—testicular cancer	0.000126	0.000868	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000125	0.000862	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—testicular cancer	0.000125	0.000861	CcSEcCtD
Fluorescein—Hypersensitivity—Epirubicin—testicular cancer	0.000122	0.000839	CcSEcCtD
Fluorescein—Urticaria—Doxorubicin—testicular cancer	0.000121	0.000837	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—testicular cancer	0.000121	0.000833	CcSEcCtD
Fluorescein—Asthenia—Epirubicin—testicular cancer	0.000119	0.000817	CcSEcCtD
Fluorescein—Pruritus—Epirubicin—testicular cancer	0.000117	0.000806	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—testicular cancer	0.000117	0.000805	CcSEcCtD
Fluorescein—Hypersensitivity—Doxorubicin—testicular cancer	0.000113	0.000776	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—testicular cancer	0.000112	0.000774	CcSEcCtD
Fluorescein—Rash—Methotrexate—testicular cancer	0.000111	0.000767	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—testicular cancer	0.000111	0.000767	CcSEcCtD
Fluorescein—Headache—Methotrexate—testicular cancer	0.000111	0.000762	CcSEcCtD
Fluorescein—Asthenia—Doxorubicin—testicular cancer	0.00011	0.000756	CcSEcCtD
Fluorescein—Dizziness—Epirubicin—testicular cancer	0.000109	0.000753	CcSEcCtD
Fluorescein—Pruritus—Doxorubicin—testicular cancer	0.000108	0.000746	CcSEcCtD
Fluorescein—Vomiting—Epirubicin—testicular cancer	0.000105	0.000724	CcSEcCtD
Fluorescein—Nausea—Methotrexate—testicular cancer	0.000105	0.000723	CcSEcCtD
Fluorescein—Rash—Epirubicin—testicular cancer	0.000104	0.000718	CcSEcCtD
Fluorescein—Dermatitis—Epirubicin—testicular cancer	0.000104	0.000717	CcSEcCtD
Fluorescein—Headache—Epirubicin—testicular cancer	0.000103	0.000713	CcSEcCtD
Fluorescein—Dizziness—Doxorubicin—testicular cancer	0.000101	0.000697	CcSEcCtD
Fluorescein—Nausea—Epirubicin—testicular cancer	9.81e-05	0.000676	CcSEcCtD
Fluorescein—Vomiting—Doxorubicin—testicular cancer	9.72e-05	0.00067	CcSEcCtD
Fluorescein—Rash—Doxorubicin—testicular cancer	9.64e-05	0.000664	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—testicular cancer	9.63e-05	0.000664	CcSEcCtD
Fluorescein—Headache—Doxorubicin—testicular cancer	9.57e-05	0.00066	CcSEcCtD
Fluorescein—Nausea—Doxorubicin—testicular cancer	9.08e-05	0.000626	CcSEcCtD
